Loading...
Corsair Gaming Inc (CRSR) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown some positive financial performance, such as revenue growth and a share repurchase program, the stock's technical indicators are bearish, and analysts have lowered price targets citing headwinds in the gaming peripherals market. Additionally, there is no significant near-term catalyst to drive the stock higher, and the options data suggests limited bullish sentiment. A hold position is recommended until clearer positive trends emerge.
The stock's technical indicators are bearish. The MACD is negatively expanding, RSI is neutral but leaning towards oversold territory, and moving averages indicate a downtrend (SMA_200 > SMA_20 > SMA_5). Key support levels are at 4.604 and 4.392, with resistance at 5.292 and 5.504. The stock is currently trading below its pivot level of 4.948, suggesting further downside risk.

Corsair Gaming reported a 12% revenue growth for 2025, reaching $1.47 billion, and announced a $50 million share repurchase program. Q4 revenue exceeded expectations, and the company achieved record gross margins.
Analysts have lowered price targets, citing memory chip shortages, softer consumer demand, and a lack of near-term catalysts. The stock has declined 41% since November 2025, and the gaming components segment is expected to remain volatile. Additionally, the company's Q3 2025 net income and EPS have significantly declined YoY.
In Q4 2025, Corsair Gaming reported revenue of $436.86 million, exceeding expectations, and a non-GAAP EPS of $0.43. For the full year 2025, revenue grew by 12% YoY to $1.47 billion, with record gross margins. However, in Q3 2025, net income dropped by 83.67% YoY, and EPS declined by 83.93%, highlighting profitability challenges.
Analysts have a mixed to cautious outlook on CRSR. B. Riley lowered the price target to $6 from $7.50, maintaining a Neutral rating, citing headwinds in the gaming peripherals market. Wedbush lowered the price target to $7 from $9 but maintained an Outperform rating, noting potential for partial spending shifts to accessible products. The consensus view reflects concerns about demand decimation due to shortages and a lack of significant near-term upside catalysts.